Scientific Sessions 2024  /  Unique Considerations for Managing ASCVD Patients with Chronic Kidney Disease  /  Management of ASCVD prior to kidney transplant- when should we revascularize?
Logo

American Heart Association

  2
  0

Final ID:

Management of ASCVD prior to kidney transplant- when should we revascularize?

If you are unable to find a person you would like to add, enter their first name, last name, email, institution, role title, and Primary or Alternate below. Only add them once you have ensured you cannot find them in the AHA Database::
  • Smilowitz, Nathaniel  ( NEW YORK UNIVERSITY MEDICAL CE , New York , New York , United States )
    • Author Disclosures:
    Nathaniel Smilowitz: DO have relevant financial relationships ; Consultant:Abbott Vascular:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Unique Considerations for Managing ASCVD Patients with Chronic Kidney Disease

Friday, 11/15/2024 , 12:30PM - 01:45PM

Cardiovascular Seminar

More abstracts on this topic:
To treat or not to treat- Lipid management in CKD patients

Gianos Eugenia, Mehta Laxmi

Best practices for peri-procedural kidney function optimization

Palevsky Paul, Weisbord Steven

More abstracts from these authors:
What To Do When Myocardial Injury after Noncardiac Surgery (MINS) Happens

Smilowitz Nathaniel, Berger Jeffrey

Panelist 4

Kaul Prashant, Smilowitz Nathaniel

You have to be authorized to contact abstract author. Please, Login
Not Available